BiotechTube
Fluart Innovative Vaccines

Fluart Innovative Vaccines

Budapest, Hungary· Est.
fluart.hu
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $4.3M

Overview

Fluart Innovative Vaccines is a pioneering Hungarian biotech with over 33 years of expertise in influenza vaccine development and manufacturing, having produced over 35 million doses. It leverages its GMP-certified facilities to provide full-spectrum CDMO services while advancing an innovative pipeline that includes next-generation influenza vaccines and bacteriophage therapies for antibiotic-resistant infections. The company is a recognized player in the global vaccine ecosystem, collaborating with international health organizations like the WHO and CDC.

Infectious Disease

Technology Platform

Influenza vaccine development/manufacturing and bacteriophage therapy platform for targeting antibiotic-resistant bacteria.

Funding History

2
Total raised:$4.3M
Grant$2.5M
Seed$1.8M

Opportunities

The growing global demand for influenza vaccines and pandemic preparedness, combined with the urgent need for solutions to antibiotic-resistant infections, creates significant market opportunities.
Expansion of its CDMO services for international biotech clients offers a scalable revenue stream alongside its proprietary pipeline.

Risk Factors

The company faces competition from large global vaccine manufacturers and depends heavily on the influenza market.
Its innovative bacteriophage program carries inherent scientific and regulatory risks associated with novel biologic therapies.
Scaling operations to compete internationally requires significant resources.

Competitive Landscape

In influenza vaccines, Fluart competes with global giants like Sanofi, Seqirus, and GSK. As a mid-sized CDMO, it competes with other regional and global contract manufacturers. In bacteriophage therapy, it is in a emerging field with a mix of small biotechs and academic spin-outs, facing an uncertain regulatory landscape.

More companies in Biologics / Biosimilars →More companies in Hungary →